SSGSX | UBVAX | SSGSX / UBVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 26 years | 21 years | - |
Gain YTD | 1.761 | 5.395 | 33% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 1000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.85B | 10.5B | 65% |
Annual Yield % from dividends | 0.35 | 1.32 | 27% |
Returns for 1 year | 1.76 | 5.12 | 34% |
Returns for 3 years | -1.81 | 6.50 | -28% |
Returns for 5 years | 7.99 | 36.18 | 22% |
Returns for 10 years | 17.10 | 58.60 | 29% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PYVAX | 19.30 | N/A | N/A |
Payden Equity Income Adviser | |||
VALLX | 39.77 | -0.29 | -0.72% |
Value Line Larger Companies Focused Inv | |||
RIRGX | 71.17 | -1.59 | -2.19% |
American Funds Capital Income Bldr R6 | |||
DUSLX | 38.27 | -1.00 | -2.55% |
DFA US Large Cap Growth Instl | |||
APGRX | 19.83 | -0.74 | -3.60% |
Yorktown Growth Institutional |